FMS vs THC
Fresenius Medical Care AG and Tenet Healthcare Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | FMS | THC |
|---|---|---|
| Revenue | $14.6B | $21.3B |
| Net income | $1.1B | $2.4B |
| Gross margin | 32.4% | — |
| Net margin | 8.6% | 11.1% |
| Return on equity | 12.2% | — |
| Diluted EPS | $3.65 | $15.49 |
| Dividend / share | — | — |
| Payout ratio | 26.7% | — |
| Free cash flow | $1.3B | $2.5B |
| Equity | $9.2B | $4.2B |
| Net debt / equity | 0.78× | 2.42× |
| Current ratio | 1.77× | 1.76× |
| Revenue CAGR 5y | 6.6% | 3.9% |
| Profit CAGR 5y | 6.3% | 25.2% |
THC bills 1.5× the revenue of FMS, and keeps more of each dollar of revenue as profit (11.1% against 8.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
6 years side by side
| Fiscal year | FMS | THC |
|---|---|---|
| FY2013 | $14.6B | $12.1B |
| FY2012 | $13.8B | $9.9B |
| FY2011 | $12.6B | $8.7B |
| FY2010 | $11.8B | $8.3B |
| FY2009 | $11.2B | $8.3B |
| FY2008 | $10.6B | $8.6B |
Net income by year
Bottom line
| Fiscal year | FMS | THC |
|---|---|---|
| FY2013 | $1.1B | $-104.0M |
| FY2012 | $1.2B | $133.0M |
| FY2011 | $1.1B | $94.0M |
| FY2010 | $978.5M | $1.2B |
| FY2009 | $891.1M | $197.0M |
| FY2008 | $817.6M | $25.0M |